Document is current
Any future updates will be listed below
-
Authors
,
Porreca, Angelo
Noale, Marianna https://orcid.org/0000-0001-7115-139X
Artibani, Walter
Bassi, Pier Francesco
Bertoni, Filippo
Bracarda, Sergio
Conti, Giario Natale
Corvò, Renzo
Gacci, Mauro
Graziotti, Pierpaolo
Magrini, Stefano Maria
Mirone, Vincenzo
Montironi, Rodolfo
Muto, Giovanni
Pecoraro, Stefano
Ricardi, Umberto
Russi, Elvio
Tubaro, Andrea
Zagonel, Vittorina
Crepaldi, Gaetano
Maggi, Stefania
- License Information
-
More Information
Article History
Received: 15 November 2017
Accepted: 4 June 2018
First Online: 13 June 2018
Ethics approval and consent to participate
: The Pros-IT CNR study protocol was approved by the Ethics Committee of the clinical coordinating center located at the Sant’Anna Hospital (Como, Italy; register number 45/2014). It was also approved by the Ethics Committees of each of the other participating centers.All participants gave informed consent.
: AP, MN, WA, PFB, FB, GNC, RC, MG, SMM, VM, RM, GM, SP, UR, VZ declare that they have no conflicts of interest. AT reports personal fees and other from Astellas, other from Allergan, other from Bayer, other from GSK, personal fees and other from Pierre Fabre, other from Takeda, outside the submitted work. SM and GC report grants from Takeda, during the conduct of the study; personal fees from Takeda, outside the submitted work. Conflict of interest forms for PG, ER and SB were not received.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
